Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients

Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients

It is increasingly evident the necessity of new predictive tools for the treatment of pancreatic ductal adenocarcinoma in a personalized manner. We present a co-clinical trial testing the predictiveness of zPDX (zebrafish patient-derived xenograft) for assessing if patients could benefit from a ther...

Full description

Bibliographic Details
Main Authors: Alice Usai, Gregorio Di Franco, Margherita Piccardi, Perla Cateni, Luca Emanuele Pollina, Caterina Vivaldi, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente, Alfredo Falcone, Dimitri Giunchi, Alessandro Massolo, Vittoria Raffa, Luca Morelli
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
zebrafish avatar
chemosensitivity
preclinical model
pancreatic cancer
personalized medicine
Online Access:https://www.mdpi.com/2072-6694/13/16/4131

Internet

https://www.mdpi.com/2072-6694/13/16/4131

Similar Items